Omega Fund Management, LLC

CIK 0001637359 · Q2 2026

13F Equity AUM

$185.7M

+13.8% QoQ

Positions

0 QoQ

AUM Rank

#8,371

Top 67%

Skill Alpha (FF)

-22.5%/yr^ns

No Clear Edge

Rank #8,262 · Top 99%

vs S&P -29.6%/yr (unadj.)

Quarters Tracked

~11 years

Portfolio Concentration

Top 5: 92.5%Top 10: 100.0%Top 20: 100.0%

BCAX29.1%

NUVB24.7%

KMTS14.0%

BBOT13.5%

BBNX11.1%

ALMS3.7%

SANA1.6%

IMA1.4%

ENGN0.8%

Odyssey Therapeutics Inc.0.0%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare100.0%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 10Median: 7.38%Avg: 10.00%

0–0.5%

1(0.0%)

0.5–1%

1(0.8%)

1–3%

2(3.0%)

3–5%

1(3.7%)

5%+

5(92.5%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 10vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New1Increased0Decreased1Exited1

New Positions

Odyssey Therapeutics…0.0%

+3K

Decreased

BCAX29.1%

-570,000(-24%)

Exited

REPL

-248,672

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...